The goal is to create industry-wide standards that simplify internal processes and encourage collaboration between sponsors, CROs, sites, and technology vendors.
KING OF PRUSSIA, PA (PRWEB) April 15, 2016
DrugDev President of Data Solutions Elisa Cascade, MBA, will join pharma industry colleagues who are innovating the clinical trials industry in panel discussions at the exclusive Executive Summit on Site Strategies and the ACRP Annual Meeting & Expo, April 16-19, in Atlanta:
Executive Summit on Site Strategies
Next-Generation Tools and Technologies: Redefining the Future of Sites
Saturday April 16, 1:45–3:00 PM
Experts will explore cutting-edge technologies, tools and approaches that are redefining clinical trials, including mobile technologies that offer the potential to increase the quality and efficiency of clinical trials by allowing for remote participation in some or all study activities, investigator-facing technologies, like single sign-on, online profiles and document templates, that create a win/win — increased efficiency for clinical trial sponsors and decreased burden for investigators and sites so that they can focus more on patient care and assessment and rating tools that optimize site performance and improve project management by measuring the influence of workload on productivity.
Moderator Steven B. Whittaker, PharmaPM Consulting, LLC will be joined by panelists:
-Gerrit S. Hamre, Clinical Trials Transformation Initiative (CTTI)
-D. Jamie Macdonald, Chief Executive Officer, INC Research
-David J. Morin, MD, RPh, FACP, CPI, Director of Research, Holston Medical Group
-Elisa Cascade, MBA, President of DrugDev Data Solutions
ACRP Annual Meeting & Expo
Standardization, Collaboration and Technology: A Global Site and Industry Perspective
Sunday, April 17, 8:30-10:30 AM
Research sites are being asked to implement a growing alphabet soup of clinical trial technologies: EDC, ePRO, eTMF, and many more. While the initial motivation behind these advances was individual company ROI, the continued high turnover of investigators has shifted the focus towards efficiencies for both sites and Industry. With the emergence of cross-company initiatives such as the Investigator Databank and TransCelerate’s Shared Investigator Platform (SIP) and Investigator Registry (IR), companies are now working together to drive even greater efficiencies for sites and Industry through collaboration and standardization, underpinned by innovative technology. The panel will examine all of these factors – standardization, collaboration and technology – from both the global site and Industry perspective, guided by results from DrugDev’s 2015 survey of 572 investigators across nine countries on global access to and use of technology by clinical trial sites.
-Munther Baara, Senior Director, Clinical Paradigm, Pfizer
-Kelly Walker, Chief Operating Officer, Research Across America
-Elisa Cascade, President DrugDev Data Solutions
Learn more about the ACRP Meeting & Expo: http://www.acrp2016.org
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for site identification and activation, workflow optimization, learning management, site and patient engagement and global site payments, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry (IR) and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at drugdev.com.